Regulatory change often does more than introduce new rules. It reveals where the industry is headed.
Illinois House Bill 5228 is one of those moments.
Once signed, this legislation will change how Utilization Review and IMEs are used to address treatment with strict new requirements:
Utilization Review (UR)
UR must be conducted based on evidence-based guidelines.
Denials or modifications for physician-requested care must be made by a physician (similar to other states).
UR decisions are good for 3 months post delivery, or duration of care with that provider, whichever is longer.
Independent Medical Exams (IME)
90-day deadline to complete and deliver IME reports.
Specialty-matched providers are required for all exams that are conducted in lieu of UR.
While much of the discussion has focused on the mechanics, including a 90-day deadline for IME completion, stricter specialty matching, and increased exposure to penalties, the broader implication is clear. The expectations around how treatment decisions are evaluated are evolving.
A Move Toward Accountability and Clinical Alignment
At its core, HB 5228 reinforces two themes that are gaining traction across jurisdictions:
Speed matters.
Claims decisions can no longer afford extended delays when treatment is in question. The 90-day requirement effectively puts claims teams “on the clock” the moment records are received.
Clinical credibility matters more.
Requiring IME physicians to be board-certified in the same specialty as the treating provider raises the bar for medical alignment. It is no longer enough to secure an opinion. That opinion must carry equivalent clinical weight.
Together, these changes signal a shift away from process-driven reviews and toward more defensible, clinically grounded decision-making.
The Operational Reality for Claims Organizations
For claims handlers and organizations, this is not just a compliance update. It is an operational challenge.
Success under HB 5228 will depend on the ability to:
Any breakdown in that chain introduces risk, not only in the form of delays, but in potential penalties and unfavorable claim outcomes.
This is where many traditional workflows begin to show strain.
Why Partner Strategy Matters More Than Ever
As requirements tighten, the role of Clinical Service Partners becomes more critical.
They are no longer just facilitating exams, but directly influencing a claim’s ability to remain compliant, timely, and defensible.
Organizations will need partners who can:
In this environment, execution is not a differentiator. It is the baseline.
Preparing for What Comes Next
HB 5228 may be specific to Illinois, but the direction is not unique. Across the industry, there is a growing emphasis on faster decision-making, stronger clinical alignment, and greater accountability in managing treatment disputes.
For claims organizations, the takeaway is simple. Preparation cannot wait until legislation is enacted. By the time the rules go into effect, processes, partners, and expectations need to already be aligned.
That is where forward-thinking teams will create separation.
A Moment of Opportunity
Regulatory changes often feel reactive. But they can also be a catalyst.
HB 5228 creates an opportunity to reassess workflows, strengthen partnerships, and build a more responsive and clinically sound IME strategy.
Those who adapt early will not just remain compliant. They will be better positioned to navigate what comes next.
For the full details on the regulation, visit HB5228 - 104th General Assembly (2025-2026)